Clinical trial
Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study
NCT03183037 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 7, 2017
- Completion date
- May 2, 2024
- Enrollment
- 75 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy, peripheral neuropathy